Angioimmunoblastic T-cell lymphoma revealed after treatment of B-cell lymphoproliferative diseases.
Kerob
Delphine
D
Arnulf
Bertrand
B
Vignon-Pennamen
Marie Dominique
MD
M'Barek
Lila Ben
LB
Agbalika
Felix
F
Rybojad
Michel
M
Cayuela
Jean Michel
JM
Briere
Josette
J
Fermand
Jean Paul
JP
Lebbe
Celeste
C
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D058846:Antibodies, Monoclonal, Murine-Derived; D001402:B-Lymphocytes; D005260:Female; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000139:chemically induced; D016399:Lymphoma, T-Cell / Q000139:chemically induced*; D008232:Lymphoproliferative Disorders / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab